Home > Insider Trading > Filing (0001264124-12-000030)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881464	Amylin Pharmaceuticals Inc	AMLN	Pharmaceutical Preparations (2834)	330266089

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1455318	P Vincent Mihalik	9360 Towne Centre Dr San Diego CA 92121	Svp, Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-08	10,000	$0.00	21,017	No	4	A	Direct
Common Stock	Disposition	2012-02-08	3,842	$16.62	17,175	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,338	Indirect	Indirect-401k
Common Stock	2,990	Indirect	by ESOP

Footnotes

Represents shares acquired upon vesting of performance-based restricted stock units.
Includes 585 shares recently acquired under the Company's Employee Stock Purchase Plan.
Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of performance-based restricted stock units.
These shares will fully vest four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment. Indirect-401k ownership includes shares acquired pursuant to the Company's 401(k) plan and includes 473.3 shares contributed to the Reporting Person's 401(k) account by the Company on February 1, 2012